A team of researchers, led by Flora Hammond, MD, found that in multiple studies of patients with chronic TBI and moderate-severe aggression, taking 100 milligrams of the antiviral drug Amantadine twice daily appeared to be beneficial in decreasing aggression, from the perspective of the patients. Their findings were published in the newest issue of the Journal of Head Trauma Rehabilitation.
Dr. Hammond said scientists initially realized the potential for Amantadine to help patients with brain injuries because people with Parkinson’s disease, a disorder of the central nervous system, showed cognitive improvements while taking the drug to prevent viruses such as the flu. This study is important, she said, because it expands treatment options for brain injury patients with aggression, which can have devastating effects on people’s lives and ability to function.
Read more at: https://www.sciencedaily.com/releases/2017/09/170911122630.htm